eNauka - pregled

Pregled prema Autor Perzeri, Andreas L

Prikaz rezultata 1 do 1 od 1
GodinaNaslovAutor(i)Tip rezultataMp-kat.
2010High Dose Imatinib Induction Therapy (800 mg/day, 6 Months) In Pre-Treated Chronic Phase CML Patients Improves Cytogenetic and Molecular Responses but Does Not Improve Overall and Progression Free Survival - Final Results of the CELSG Phase III CML11 "ISTPerzeri, Andreas L; ...; Bogdanovic, Andrija D  ; ...; (broj, koautora 20)Konferencijski rad
Mp kategorija će biti prikazana naknadno.